Navegar por autor "Provencio, M."

Mostrando ítems 1-9 de 9

Agreement Between Different Methodologies for Non-Invasive p.T790M and EGFR Sensitizing Mutation Testing

2019- Romero, A.; Jantus, E.; Molina-Vila, M. A.; Insa, A.; Cruz, P.; [et al.]
ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing

2022- Sánchez-Herrero, E.; Campos-Silva, C.; Cáceres-Martell, Y.; Robado De Lope, L.; Sanz-Moreno, S.; [et al.]
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

2022- Provencio, M.; Cobo, M.; Rodriguez-Abreu, D.; Calvo, V.; Carcereny, E.; [et al.]
Indoor Radon and Lung Cancer Risk. A Pooling Study on the Second Risk Factor for Lung Cancer

2019- Ruano-Ravina, A.; Lorenzo-Gonzalez, M.; Provencio, M.; Torres Durán, María Luisa; Parente Lamelas, Isaura; [et al.]
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer

2023- Janik, A.; Torrente, M.; Costabello, L.; Calvo, V.; Walsh, B.; [et al.]
Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020

2023- Pérez Ríos, Mónica; López-Medina, D.C.; Guerra-Tort, C.; Rey-Brandariz, J.; Varela Lema, Leonor; [et al.]
Occupation as a risk factor of small cell lung cancer

2023- García, T.C.; Ruano Raviña, Alberto; Candal-Pedreira, C.; López López, Rafael; Torres Durán, María Luisa; [et al.]
Reccurrence Pattern After Adjuvant Customized Chemotherapy Based on BRCA Expression Level (SCAT Trial)

2019- Massuti, B.; Sanchez, J. M.; Cobo, M.; Moran, T.; Larriba, J. L. G.; [et al.]
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

2022- Casarrubios, M.; Provencio, M.; Nadal, E.; Insa, A.; García Campelo, María del Rosario; [et al.]